| |
ATC |
 1 Agents affecting nervous system and sensory organs
|
|
|
2 Agents affecting individual organs
|
|
|
3 Agents affecting metabolism
|
|
|
4 Agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
 6 Agents against pathologic organisms and parasites
|
61 Antibiotics
|
62 Chemotherapeutics
|
621 Sulfonamides
|
622 Tuberculosis preparations
|
623 Leprostatics
|
624 Synthetic antibacterials
|
6241 Pyridonecarboxylic acids
|
 D00453 Ofloxacin (JP17/USP/INN)
D00186 Ciprofloxacin (JP17/USP/INN)
D02216 Ciprofloxacin hydrochloride (USP); Ciprofloxacin hydrochloride hydrate (JP17)
D00210 Norfloxacin (JP17/USP/INN)
D00873 Lomefloxacin hydrochloride (JAN/USAN)
D00588 Levofloxacin (USP); Levofloxacin hydrate (JP17)
D00874 Moxifloxacin hydrochloride (JAN/USP)
D01144 Prulifloxacin (JAN/INN)
D05382 Pazufloxacin mesilate (JP17)
D02540 Garenoxacin mesylate (USAN); Garenoxacin mesilate hydrate (JAN)
D02475 Sitafloxacin (USAN); Sitafloxacin hydrate (JAN)
D01996 Tosufloxacin tosylate hydrate (JP17)
D10772 Lascufloxacin hydrochloride (JAN)
D01531 Pipemidic acid hydrate (JP17)
|
J01MA01 S01AE01 S02AA16
J01MA02 S01AE03 S02AA15 S03AA07
J01MA02 S01AE03 S02AA15 S03AA07
J01MA06 S01AE02
J01MA07 S01AE04
J01MA12 S01AE05
J01MA14 S01AE07
J01MA17
J01MA18
J01MA19
J01MA21
J01MA22
J01MA25
J01MB04
|
6249 Others
|
625 Antivirals
|
629 Miscellaneous
|
63 Biological preparations
|
64 Parasitics (systemic)
|
69 Other agents against pathogenic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan